Brain: Tumours

(asked on 23rd March 2026) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will publish the status of each work package within the NIHR Brain Tumour Consortium, including submission date, status, date of the latest decision and correspondence and reasons for any delay and return.


Answered by
Zubir Ahmed Portrait
Zubir Ahmed
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 30th March 2026

The Department invests over £1.7 billion per year in research through the National Institute for Health and Care Research (NIHR).

We are committed to furthering our investment in brain cancer research and have already taken steps to stimulate scientific progress and build scientific capacity to do research on brain cancer.

In January 2026, the NIHR announced increased investment of over £25 million in the NIHR Brain Tumour Research Consortium. The world-leading consortium aims to transform outcomes for adults and children and their families who are living with brain tumours, ultimately reducing lives lost to cancer.

The NIHR Funding Committee meeting for the NIHR Brain Tumour Research Consortium and associated work packages took place on 14 October 2025. The outcomes of which are made publicly available on the NIHR website. The following table shows the NIHR Brain Tumour Research Consortium funding awards and their decision status:

Award Title

Decision

NIHR501957 - The Brain Tumour Novel Therapeutics Consortium

Conditional offer

NIHR502152 - WP1 - Adult Early Phase 5G platform

Conditional offer

NIHR501153 - WP2 Adult Graduation Phase 5G platform

Declined with possibility to resubmit

NIHR501826 - TarGeT (Targeted pedicatric high-grade Glioma Therapy) phase 2 umbrella trial

Conditional offer

NIHR501825 - EPILOGUE- Phase I/II combination umbrella trial in relapsed paediatric low-grade glioma

Conditional offer


The Brain Tumour Novel Therapeutics Consortium contract commenced in December 2025. Associated work packages were issued and intent to fund letters sent in December 2025, although this is contingent upon submitting and reviewing detailed costs and, if applicable, agreeing to the suggested amendments and requests for clarification, which are currently in progress.

The NIHR is working to ensure that new investments can get up and running as soon as possible. We are expecting to make further announcements in due course.

Reticulating Splines